We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

179 hedge funds and large institutions have $888M invested in Ariad Pharmaceuticals Inc in 2014 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 49 increasing their positions, 50 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

55% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 22

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

36% more capital invested

Capital invested by funds: $655M → $888M (+$233M)

6% more funds holding

Funds holding: 169 → 179 (+10)

2% less repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 50

8% less call options, than puts

Call options by funds: $32M | Put options by funds: $34.7M

Holders
179
Holders Change
+10
Holders Change %
+5.92%
% of All Funds
4.77%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.16%
New
34
Increased
49
Reduced
50
Closed
22
Calls
$32M
Puts
$34.7M
Net Calls
-$2.74M
Net Calls Change
+$3.27M

Top Buyers

Rank Fund Capital Flow
1
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$52M
2
PI
Putnam Investments
Massachusetts
+$18.8M
3
PC
PointState Capital
New York
+$10.3M
4
CCM
Camber Capital Management
Massachusetts
+$9.38M
5
AIMCA
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
+$8.63M

Top Sellers

Rank Fund Capital Flow
1
HM
HealthCor Management
New York
-$12.8M
2
Millennium Management
Millennium Management
New York
-$8.89M
3
DFO
Duquesne Family Office
New York
-$8.88M
4
JP Morgan Chase
JP Morgan Chase
New York
-$6.85M
5
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$6.25M
Name Holding Trade Value Shares
Change 		Change in
Stake
WPP
126
Whalerock Point Partners
Rhode Island
$144K +$18.8K +3,000 +17%
ACM
127
Apex Capital Management
Ohio
$139K +$27.4K +4,379 +28%
M&T Bank
128
M&T Bank
New York
$138K -$44.4K -7,100 -26%
US Bancorp
129
US Bancorp
Minnesota
$125K +$60K +9,597 +112%
LPL Financial
130
LPL Financial
California
$120K -$404K -64,600 -79%
PAM
131
Princeton Alpha Management
New Jersey
$120K +$109K +17,416 New
Prudential Financial
132
Prudential Financial
New Jersey
$117K -$35.6K -5,700 -25%
ID
133
Integral Derivatives
New York
$115K +$28.1K +4,500 +37%
CSS
134
Cubist Systematic Strategies
Connecticut
$112K +$102K +16,257 New
AB
135
Amalgamated Bank
New York
$111K +$150 +24 +0.1%
DCM
136
Dynamic Capital Management
Jersey
$109K +$99.5K +15,905 New
Parallax Volatility Advisers
137
Parallax Volatility Advisers
California
$103K -$37.1K -5,930 -28%
AIP
138
Ameritas Investment Partners
Nebraska
$101K – – –
N
139
Nuveen
North Carolina
$88K -$3.21K -513 -4%
BCM
140
Bienville Capital Management
New York
$82K +$75.1K +12,000 New
Canada Life
141
Canada Life
Manitoba, Canada
$72K – – –
FDCC
142
Foster Dykema Cabot & Co
Massachusetts
$70K – – –
Bank of Montreal
143
Bank of Montreal
Ontario, Canada
$70K +$28.5K +4,550 +79%
MIAN
144
Mariner Independent Advisor Network
Kansas
$68.7K +$62.5K +10,000 New
Creative Planning
145
Creative Planning
Kansas
$65K -$50.3K -8,050 -46%
Teacher Retirement System of Texas
146
Teacher Retirement System of Texas
Texas
$37K -$6.34K -1,013 -16%
RIA
147
Regal Investment Advisors
Michigan
$34K – – –
BPBT
148
Boston Private Bank & Trust
Massachusetts
$34K +$31.3K +5,000 New
BlackRock
149
BlackRock
New York
$33K – – –
EWM
150
Edge Wealth Management
New York
$24K -$12.5K -2,000 -36%
4 5
6
7 8

ARIA Hedge Fund Activity: Q4 2014 in Review

179 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q4 2014, worth a combined $888M — up 36% from $655M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new ARIA positions and 22 closed out — a net gain of 12 holders — while 49 added to existing stakes and 50 trimmed.

The largest buyer was Westfield Capital Management, opening a new position worth an estimated $52M. The largest seller was HealthCor Management, exiting entirely with an estimated $12.8M sold.

  • 179 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q4 2014, up from 169 in Q3 2014.
  • Funds reported $888M of Ariad Pharmaceuticals Inc stock for Q4 2014, up 36% quarter-over-quarter.
  • 34 funds opened new Ariad Pharmaceuticals Inc positions in Q4 2014 and 22 closed out, a net change of +12 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q4 2014 was Westfield Capital Management, an estimated $52M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q4 2014 was HealthCor Management, an estimated $12.8M sold.

Based on aggregated 13F filings for Q4 2014.